Chagas' Disease — Can We Stop the Deaths?
- 24 August 2006
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 355 (8) , 760-761
- https://doi.org/10.1056/nejmp068130
Abstract
Nearly 100 years since its discovery by the Brazilian physician Carlos Chagas, the protozoan parasite Trypanosoma cruzi remains perhaps the most common cause of myocarditis worldwide. The lethality of Chagas' heart disease is undisputed, as the survival curves presented by Rassi et al. in this issue of the Journal illustrate with chilling clarity (pages 799–808). More than 10 million Latin Americans carry the parasite, and at least 1 million of them will die unless scientific and political breakthroughs lead to new strategies and tools for diagnosis, treatment, and increased access to medical care.1 Chagas' disease (American trypanosomiasis) afflicts impoverished people . . .Keywords
This publication has 5 references indexed in Scilit:
- Development and Validation of a Risk Score for Predicting Death in Chagas' Heart DiseaseNew England Journal of Medicine, 2006
- Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No TreatmentAnnals of Internal Medicine, 2006
- The Genome Sequence of Trypanosoma cruzi , Etiologic Agent of Chagas DiseaseScience, 2005
- SHORT REPORT: BENZNIDAZOLE EFFICACY AMONG TRYPANOSOMA CRUZI-INFECTED ADOLESCENTS AFTER A SIX-YEAR FOLLOW-UPThe American Journal of Tropical Medicine and Hygiene, 2004
- Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community.Circulation, 1987